Full side-by-side comparison — 2026
Data as of May 20, 2026 · Updated automatically
| Metric | JNJ | MMM |
|---|---|---|
| Current Price | 230.48 | 151.74 |
| Previous Close | 229.32 | 149.78 |
| Metric | JNJ | MMM |
|---|---|---|
| Trailing P/E | 26.24 | 29.39 |
| Forward P/E | 17.84 | 16.13 |
| Price / Book | 6.72 | 24.38 |
| Price / Sales | 5.66 | 3.18 |
| EV / EBITDA | 16.86 | 13.93 |
| Metric | JNJ | MMM |
|---|---|---|
| Dividend Yield | 0.0229% | 0.0203% |
| Dividend Rate (Annual) | 5.20 | 2.97 |
| 5-Year Avg Yield | 2.77% | 4.21% |
| Payout Ratio | 0.5952% | 0.5662% |
| Metric | JNJ | MMM |
|---|---|---|
| Beta (Volatility) | 0.26 | 1.09 |
| Debt / Equity | 67.73 | 396.50 |
| Quick Ratio | 0.69 | 1.06 |
| Current Ratio | 1.03 | 1.59 |
| Metric | JNJ | MMM |
|---|---|---|
| Revenue Growth | 0.0990% | 0.0130% |
| Earnings Growth | -0.5290% | -0.3970% |
| Return on Equity | 0.2642% | 0.7146% |
| Revenue / Share | 40.02 | 46.89 |
| Trailing EPS | 8.64 | 5.19 |
| Forward EPS | 12.71 | 9.46 |
| Metric | JNJ | MMM |
|---|---|---|
| Analyst Mean Target | 252.96 | 173.43 |
| Analyst High Target | 285.00 | 230.00 |
| Analyst Low Target | 155.00 | 120.00 |
3M Company (MMM) leads on 10 of 19 comparable metrics.
3M Company is the stronger pick for income investors, while Johnson & Johnson may appeal to other areas.
This comparison is based on publicly available financial data and is for informational purposes only. It is not investment advice. Past performance does not guarantee future results.
MMM carries 396x debt-to-equity — significantly higher than JNJ's 68x. High leverage amplifies both gains and losses.
JNJ's earnings declined 53% — declining profits may mean current valuation metrics (PE, payout ratio) are misleading.
MMM's earnings declined 40% — declining profits may mean current valuation metrics (PE, payout ratio) are misleading.
Based on analyst mean price targets. Estimates are not guaranteed and may not reflect future performance.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in …
View JNJ details →3M Company provides diversified technology services in the America, the Asia Pacific, Europe, the Middle East, Africa, and internationally. It operates through three segments: Safety and Industrial, Transportation and Electronics, and Consumer. The Safety and Industrial segment provides industrial abrasives and finishing for metalworking applications; autobody repair solutions; industrial specialty products, such as personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, …
View MMM details →Add both to AllInvestView and compare their real-time performance, dividends, and gain/loss side by side.
Start Free Portfolio